Staccato Loxapine in Agitation (Proof of Concept)
NCT00369577
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
129
Enrollment
UNKNOWN
Sponsor class
Conditions
Schizophrenia
Interventions
DRUG:
Inhaled Placebo
DRUG:
Inhaled Loxapine 5 mg
DRUG:
Inhaled Loxapine 10 mg
Sponsor
Alexza Pharmaceuticals, Inc.